Radiosensitizing effects of trabectedin on human A549 lung cancer cells and HT-29 colon cancer cells.
DNA double-strand breaks
Trabectedin
cancer cells
irradiation
Journal
Investigational new drugs
ISSN: 1573-0646
Titre abrégé: Invest New Drugs
Pays: United States
ID NLM: 8309330
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
05
07
2019
accepted:
30
08
2019
pubmed:
5
9
2019
medline:
10
9
2021
entrez:
5
9
2019
Statut:
ppublish
Résumé
Background and Purpose Trabectedin is a unique alkylating agent with promising effects against a range of solid tumors. In this study, we aimed to examine the cytotoxic and radiosensitizing effects of trabectedin on two human epithelial tumor cell lines in vitro, and its effects on DNA repair capacity. Methods Cancer cells (A549: human lung cancer cells, HT-29: colon cancer cells) were treated with either trabectedin alone for the determination of their growth, or in combination with radiation for the determination of their metabolic activity, proliferation, and clonogenic survival. Besides, the γH2AX foci assay was performed for the assessment of ionizing radiation-induced DNA damage and to evaluate the influence of trabectedin on DNA damage repair. Results Treatment with trabectedin resulted in a growth-inhibiting effect on both cell lines, with the IC
Identifiants
pubmed: 31482373
doi: 10.1007/s10637-019-00852-x
pii: 10.1007/s10637-019-00852-x
doi:
Substances chimiques
Antineoplastic Agents
0
Trabectedin
ID0YZQ2TCP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM